Literature DB >> 30630988

Poor performance of D-dimer in excluding venous thromboembolism among patients with lymphoma and leukemia.

Aiham Qdaisat1, Rawan Al Soud2,3, Carol C Wu4, Cristhiam M Rojas Hernandez5, Jieli Li6, Qing H Meng6, Hikmat Abdel-Razeq3, Sai-Ching Jim Yeung7,8.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30630988      PMCID: PMC6545857          DOI: 10.3324/haematol.2018.211466

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

Review 1.  Mechanisms and risk factors of thrombosis in cancer.

Authors:  Anna Falanga; Laura Russo; Viola Milesi; Alfonso Vignoli
Journal:  Crit Rev Oncol Hematol       Date:  2017-08-25       Impact factor: 6.312

Review 2.  Oncogenes and the coagulation system--forces that modulate dormant and aggressive states in cancer.

Authors:  Nathalie Magnus; Esterina D'Asti; Brian Meehan; Delphine Garnier; Janusz Rak
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

Review 3.  Biomarkers for prediction of venous thromboembolism in cancer.

Authors:  Ingrid Pabinger; Johannes Thaler; Cihan Ay
Journal:  Blood       Date:  2013-08-01       Impact factor: 22.113

4.  D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.

Authors:  Cihan Ay; Rainer Vormittag; Daniela Dunkler; Ralph Simanek; Alexandru-Laurentiu Chiriac; Johannes Drach; Peter Quehenberger; Oswald Wagner; Christoph Zielinski; Ingrid Pabinger
Journal:  J Clin Oncol       Date:  2009-07-27       Impact factor: 44.544

Review 5.  D-Dimer for venous thromboembolism diagnosis: 20 years later.

Authors:  M Righini; A Perrier; P De Moerloose; H Bounameaux
Journal:  J Thromb Haemost       Date:  2008-07-01       Impact factor: 5.824

Review 6.  Venous thromboembolism and cancer: risks and outcomes.

Authors:  Agnes Y Y Lee; Mark N Levine
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

7.  Disseminated intravascular coagulation in acute leukemia at presentation and during induction therapy.

Authors:  Ashish Dixit; Tathagat Chatterjee; Pravas Mishra; Meganathan Kannan; Dharma R Choudhry; Manoranjan Mahapatra; V P Choudhry; Renu Saxena
Journal:  Clin Appl Thromb Hemost       Date:  2007-07       Impact factor: 2.389

8.  Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study.

Authors:  Marc Righini; Josien Van Es; Paul L Den Exter; Pierre-Marie Roy; Franck Verschuren; Alexandre Ghuysen; Olivier T Rutschmann; Olivier Sanchez; Morgan Jaffrelot; Albert Trinh-Duc; Catherine Le Gall; Farès Moustafa; Alessandra Principe; Anja A Van Houten; Marije Ten Wolde; Renée A Douma; Germa Hazelaar; Petra M G Erkens; Klaas W Van Kralingen; Marco J J H Grootenboers; Marc F Durian; Y Whitney Cheung; Guy Meyer; Henri Bounameaux; Menno V Huisman; Pieter W Kamphuisen; Grégoire Le Gal
Journal:  JAMA       Date:  2014-03-19       Impact factor: 56.272

9.  Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer.

Authors:  Luc Y Dirix; R Salgado; R Weytjens; C Colpaert; I Benoy; P Huget; P van Dam; A Prové; J Lemmens; P Vermeulen
Journal:  Br J Cancer       Date:  2002-02-01       Impact factor: 7.640

10.  Modelling pulmonary microthrombosis coupled to metastasis: distinct effects of thrombogenesis on tumorigenesis.

Authors:  Colin E Evans; Asis Palazon; Jingwei Sim; Petros A Tyrakis; Alice Prodger; Xiao Lu; Saria Chan; Pär-Ola Bendahl; Mattias Belting; Love Von Euler; Helene Rundqvist; Randall S Johnson; Cristina Branco
Journal:  Biol Open       Date:  2017-05-15       Impact factor: 2.422

View more
  3 in total

1.  Normal D-dimer levels in cancer patients with radiologic evidence of pulmonary embolism.

Authors:  Aiham Qdaisat; Carol C Wu; Sai-Ching Jim Yeung
Journal:  J Thromb Thrombolysis       Date:  2019-07       Impact factor: 2.300

2.  Clinical characteristics, management, and outcome of incidental pulmonary embolism in cancer patients.

Authors:  Aiham Qdaisat; Mona Kamal; Aisha Al-Breiki; Biman Goswami; Carol C Wu; Shouhao Zhou; Terry W Rice; Kumar Alagappan; Sai-Ching Jim Yeung
Journal:  Blood Adv       Date:  2020-04-28

3.  Systematic review of observational studies reporting antiphospholipid antibodies in patients with solid tumors.

Authors:  Noha Abdel-Wahab; Jean H Tayar; Faisal Fa'ak; Gaurav Sharma; Maria A Lopez-Olivo; Abdelrahman Yousif; Tasneam Shagroni; Sami Al-Hawamdeh; Cristhiam M Rojas-Hernandez; Maria E Suarez-Almazor
Journal:  Blood Adv       Date:  2020-04-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.